Outpatient lung cancer procedure promising for inoperable disease

December 01, 2004

CHICAGO - Lung cancer patients who are poor candidates for surgery have a new alternative with image-guided radiofrequency ablation (RFA), a safe and effective office-based procedure, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

"Experience leads me to believe that as lung cancer detection improves, we eventually will be able to avoid surgery by eradicating early-stage lung cancer with minimally invasive means," said study co-author Damian Dupuy, M.D., professor of diagnostic imaging at Brown Medical School and director of ultrasound in the Office of Minimally Invasive Therapy at Rhode Island Hospital in Providence.

Dr. Dupuy and colleagues studied 155 image-guided RFA lung procedures over six years on 126 medically inoperable patients, who had a total of 163 lesions. RFA uses a specially designed needle connected to a radiofrequency generator that delivers electrical current to ablate, or "cook," tumors. Computed tomography (CT) or ultrasound is used to guide the needle to the tumor site for ablation.

"Although the patients we treated were poor surgical candidates, the procedures went very well," Dr. Dupuy said. "Our complication rate was low, and morbidity and mortality rates were lower than those of lung surgery. Plus, RFA is an outpatient procedure with a tremendously condensed recovery period."

Approximately 174,000 Americans are diagnosed with lung cancer each year, according to the American Cancer Society, but Dr. Dupuy said surgery is not an option for the majority of them. In many cases the disease is too extensive for surgical removal, or there is an underlying disease such as emphysema, heart disease or other medical problems. Traditionally, these patients are treated with chemotherapy or radiation.

Dr. Dupuy and colleagues determined that RFA alone or in conjunction with chemotherapy and radiation therapy is safe and feasible for treatment of primary lung tumors and tumors that metastasize from other parts of the body.

"The outpatient RFA procedure effectively controls small tumors, allowing these patients to avoid surgery," Dr. Dupuy said.

RFA is particularly beneficial for patients who have a lung cancer recurrence or regrowth and cannot have additional surgery or radiation therapy, Dr. Dupuy said.

"Ablation can relieve pain and control local symptoms in these patients," Dr. Dupuy said. "It does not necessarily extend their lives, but it can improve their quality of life."

Co-authors study are Caroline J. Simon, M.D., William W. Mayo-Smith, M.D., Thomas A. DiPetrillo, M.D., and Neal E. Ready, M.D.
-end-
Note: Copies of RSNA 2004 news releases and electronic images will be available online at RSNA.org/press04 beginning Monday, Nov. 29.

RSNA is an association of more than 37,000 radiologists, radiation oncologists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook, Ill.

Editor's note: The data in these releases may differ from those in the printed abstract and those actually presented at the meeting, as researchers continue to update their data right up until the meeting. To ensure you are using the most up-to-date information, please call the RSNA Newsroom between Nov. 27 and Dec. 3 at 312-949-3233.

Radiological Society of North America

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.